CU-CPT22 - Toll-like Receptor (TLR) 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第1頁
CU-CPT22 - Toll-like Receptor (TLR) 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第2頁
CU-CPT22 - Toll-like Receptor (TLR) 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第3頁
CU-CPT22 - Toll-like Receptor (TLR) 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第4頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemECU-CPT22Cat. No.: HY-108471CAS No.: 1416324-85-0分式: CHO分量: 362.37作靶點: Toll-like Receptor (TLR)作通路: Immunology/Inflammation儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 125 mg/mL (344.95 m

2、M)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.90 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (6.90 mM); Suspended solution; Need ultrasonic1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemE3. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility:

3、 2.5 mg/mL (6.90 mM); Suspended solution; Need ultrasonicBIOLOGICAL ACTIVITY物活性 CU-CPT22種 toll 樣受體 1 和 2 (TLR1/2) 抑制劑, 其 IC50 值為 0.58 M。IC50 & Target IC50: 0.58 M (TLR1/2) 1體外研究 CU-CPT22 is a toll-like receptor 1 and 2 (TLR1/2) inhibitor with an IC50 of 0.580.09 M. It is demonstratedthat CU-CPT22 is

4、 able to compete with Pam3CSK4 for binding to TLR1/2 with an inhibition constant (Ki) of0.410.07 M, which is consistent with its potency observed in the whole cell assay. Increasing theconcentration of CU-CPT22 to 6 M decreases the anisotropy to background levels. It is found that CU-CPT22 inhibits

5、TLR1/2 signaling without affecting other TLRs, showing it is highly selective in intact cells.CU-CPT22 is found to have no significant cytotoxicity at various concentrations up to 100 M in RAW 264.7cells. The result demonstrates that CU-CPT22 can inhibit about 60% of TNF-and 95% of IL-1 at 8 M 1.PRO

6、TOCOLKinase Assay 1 RAW 264.7 cells are planted in 6-well plates at 1,000,000 cells per well with 3 mL of medium and grown for24 h at 37C in a 5% CO2 humidified incubator. After 24 h, non-adherent cells and media are removed andreplaced with fresh RPMI 1640 medium (3 mL/well). Two wells of adherent

7、macrophages are treated withPam3CSK4 (300 ng/mL) as the positive control, two wells are treated with 8 M CU-CPT22, and the othertwo wells are treated with 8 M compound DMSO. Plates are then incubated for an additional 24 h. Themedium is removed, the cells are washed with PBS (31 mL), the plate is pu

8、t on ice, then 500 L of lysisbuffer is added to each well. The production of the cytokine interleukin-1 (IL-1) and TNF- is quantifiedwith enzyme-linked immunosorbent assays (ELISA). The cytokine level in each sample is determined induplicate 1.MCE has not independently confirmed the accuracy of thes

9、e methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻 Oxid Med Cell Longev. 2019 Apr. Life Sci. 2019 May 1;224:212-221.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Cheng K, et al. Discovery of small-molecule inhibitors of the TLR1/TLR2 complex. Angew Chem Int Ed Engl. 2012 Dec 3;51(49):12246-9.McePdfHeight2/2 Master of Small Molecules 您邊的抑制劑師www.MedChemECaution: Product has not been fully validated for me

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論